Subrabrata Sen

Title: Celebrating the Innovations of Inventor Subrabrata Sen

Introduction

Subrabrata Sen, an accomplished inventor based in Sunnyvale, California, has made significant contributions to the field of pharmaceuticals. With two patents to his credit, he stands out for his work on compounds that have the potential to address critical health challenges.

Latest Patents

Sen's latest innovations focus on substituted piperazines, particularly compounds that act as potent antagonists of the CCR1 receptor. These compounds have been validated through animal testing, showing promise for treating inflammation, which is a primary concern in CCR1-mediated diseases. The aryl piperazine derivatives he has developed are not only useful in pharmaceutical compositions and methods for treating such diseases but also serve as controls in assays designed to identify competitive CCR1 antagonists.

Career Highlights

Currently, Subrabrata Sen is associated with ChemoCentryx, Inc., where he applies his expertise to develop groundbreaking therapies. His work has positioned him as a valued contributor in the field, further demonstrating his dedication to advancing medical science through innovation.

Collaborations

Throughout his career, Sen has collaborated with notable colleagues, including James Bradley Aggen and JJ Kim Wright. These partnerships underscore the collective effort in pushing the boundaries of pharmaceutical research and development.

Conclusion

Subrabrata Sen is a prominent figure in the realm of pharmaceutical innovation, with patents that reflect his commitment to tackling challenging health issues. His contributions not only enhance our understanding of CCR1-mediated diseases but also pave the way for future therapeutic developments in this critical area of medicine.